Loading company…
TALOS develops algorithms that predict disease risks using medical data.
Founded in 2021 and based in Seoul, South Korea, TALOS develops algorithms to assess risks of serious diseases using medical data. Its ANRISK service predicts cerebral aneurysm risk from health examination information to support early testing and care. In December 2023, it raised KRW 3.8 billion in Series A funding from Premier Partners, BA Partners, and Medinno Partners. The company planned to expand its platform, hire key staff, and enter overseas examination markets.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in